Validating the Market for a new Diagnostic

Cogentum has recently completed a project within the Australian and American markets seeking to uncover the likely acceptance and adoption levels of a new breakthrough diagnostic technology. The Project for Sienna Cancer Diagnostics provided the team with some invaluable insight into the needs of urologists. For more information visit the Sienna website.